Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
Alternativ können Sie versuchen, selbst über Ihren lokalen Bibliothekskatalog auf das gewünschte Dokument zuzugreifen.
Bei Zugriffsproblemen kontaktieren Sie uns gern.
Cover -- Half Title -- Title Page -- Copyright Page -- Dedication -- Table of Contents -- Preface -- Acknowledgments -- Authors -- 1. Mathematical Modeling Approach to COVID-19: Vetted Real Data -- 1.1 Introduction -- 1.1.1 Main Objectives of This Book -- 1.2 Anatomical Structure of COVID-19 Virus -- 1.3 Virus Incubation Period -- 1.3.1 Disease Carriers -- 1.3.2 Case Fatality Rate (CFR, %) -- 1.3.3 COVID-19 Transmission Mechanisms -- 1.4 Epidemiological Aspects of nCov2019 (SARS-Cov-19) -- 1.5 Economic Impacts of Novel Coronavirus -- 1.6 Mathematical Model for the Prediction of Novel Coronavirus (nCov2019) -- 1.6.1 Variables Used for Model Building -- 1.6.2 Endemic and Epidemic Equilibria -- 1.7 Model Discussion -- 1.7.1 Model Conclusions -- 1.8 Epidemiological Model for the Estimation of Hazard Rate and Geometric Progression of nCov2019 -- 1.8.1 Formulation of the Epidemiological Risk Assessment COVID Model -- 1.9 Epidemiological Model Approach of New Diseases -- 1.9.1 Model Formulation -- 1.9.1.1 Latent growth model of novel coronavirus -- 1.9.2 Gauss-Markov Theorem (GMT) -- 1.9.3 Maximum Likelihood Estimation (MLE) of Gauss-Markov Theorem (GMT) -- 1.9.4 Gauss-Markov Weighted Least Squares Analysis -- 1.10 Susceptible-Infective-Recovered (SIR) Epidemiological Model of COVID -- 1.10.1 Model Formulation -- 1.10.2 SIR Model Discussion -- 1.11 EP Model with Varying Population -- 1.11.1 Reproduction Number Approach to Binomial Distribution (R[sub(0)]) -- 1.12 Machine Learning Model for SARS-Cov-19 -- 1.12.1 Machine Learning Model -- 1.13 Models of Machine Learning -- 1.13.1 Measurement Error (u) -- 1.13.2 Stochastic Error (u) -- 1.13.3 Hidden Gauss-Markov Theorem (HGMT) -- 1.14 COVID-19 Mathematical Model Approach to Selective Sample -- 1.14.1 Model Formulation -- 1.15 Recommendations -- 1.16 Study Limitations -- 1.17 Conflict of Interest.
In: A Chapman & Hall Book
"This book will explore and formulate new mathematical/statistical and epidemiological modelling based on the research findings. It covers all the aspects of mitigation, estimation of transmission rate, control measures, economic impact assessment, genetic complexity of COVID and herd immunity"--
Problem melden